2022
DOI: 10.1016/j.cej.2022.136864
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic biology-powered biosensors based on CRISPR/Cas mediated cascade signal amplification for precise RNA detection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 40 publications
1
6
0
Order By: Relevance
“…Significant advancements have been made in synthetic biology to manage pulmonary disorders [248]. These advances encompass various in vitro diagnostic platforms, including biosensing systems that leverage CRISPR/Cas technology and synthetic RNAs designed for the efficient identification of biomarkers linked to lung diseases [249]. Consequently, these developments hold promise for enhancing patient well-being and health outcomes.…”
Section: Synthetic Biology-based Diagnosticsmentioning
confidence: 99%
See 1 more Smart Citation
“…Significant advancements have been made in synthetic biology to manage pulmonary disorders [248]. These advances encompass various in vitro diagnostic platforms, including biosensing systems that leverage CRISPR/Cas technology and synthetic RNAs designed for the efficient identification of biomarkers linked to lung diseases [249]. Consequently, these developments hold promise for enhancing patient well-being and health outcomes.…”
Section: Synthetic Biology-based Diagnosticsmentioning
confidence: 99%
“…Zhang et al employed a cell-free, synthetic biologydriven biosensing strategy known as SHARK [249]. This approach regulates cell-free enzyme synthesis by utilizing activated Cas13a profiling to amplify RNA signals efficiently and accurately.…”
Section: Synthetic Biology-based Diagnosticsmentioning
confidence: 99%
“…In this section, we will explain two examples of different electrical sensors to detect lung cancer cells. The first example is Zhang et al [ 112 ] developing a new biosensing strategy called SHARK (Synthetic Enzyme Shift RNA Signal Amplifier Related Cas13a Knockdown Reaction) for lung cancer detection. SHARK has broad compatibility and can be used as a portable SARS-CoV-2 biosensor with high sensitivity and selectivity, consistent with qRT-PCR results.…”
Section: Lab-on-a-chip In Cancer Detectionmentioning
confidence: 99%
“…Among various viral RNA detection methods, molecular diagnostic methods can detect viral RNA quickly and accurately with high sensitivity and specificity. [6,7] Reverse transcriptase polymerase chain reaction (RT-PCR) is considered the gold standard method, and several RT-PCR approaches for viral detection have been reported. [8][9][10] However, RT-PCR has a long turnaround time and requires an expensive thermal cycler, which is a bottleneck in resource-limited settings.…”
Section: Introductionmentioning
confidence: 99%